MEDICAL SCIENCES Correction for “Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs,” by Vincent Jacques, Anthony W. Czarnik, Thomas M. Judge, Lex H. T. Van der Ploeg, and Sheila H. DeWitt, which appeared in issue 12, March 24, 2015, of Proc Natl Acad Sci USA (112:E1471–E1479; first published March 9, 2015; 10.1073/pnas.1417832112).
The authors note that Fig. 1 appeared incorrectly. The corrected figure and its legend appear below.
Fig. 1.
Structures of thalidomide, pomalidomide, lenalidomide, and protonated and deuterated enantiomers of compound 1 [CC-11006; i.e., (S)-H-1, (R)-H-1, (S)-D-1, and (R)-D-1] as well as protonated and deuterated enantiomers of compound 2 [CC-122; (S)-H-2, (R)-H-2, (S)-D-2, and (R)-D-2 (absolute configuration was not established for compound 2; enantiomers are referred to by the sign of their optical rotation; i.e., (+) or (−); details in the text)].